TLDR AGA linked to worse COVID-19 outcomes in men.
This document discusses the correlation between androgenetic alopecia (AGA) and COVID-19 outcomes. Several studies have found that AGA is more prevalent in COVID-19 patients than in the general population, and that the presence of the Gabrin sign (a skin manifestation of COVID-19) is associated with a higher prevalence of AGA. The severity of AGA, as measured by the Hamilton-Norwood scale, is also associated with worse outcomes in hospitalized men. The document suggests that AGA may be a risk factor for severe COVID-19 outcomes in men, and encourages further research on the topic.
6 citations,
July 2020 in “Journal of The American Academy of Dermatology” Hair loss link to severe COVID-19 unclear.
119 citations,
May 2020 in “Journal of The American Academy of Dermatology” Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.
123 citations,
May 2020 in “Drug Development Research” Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.
155 citations,
December 2003 in “British Journal of Dermatology” Hair loss increases with age; alcohol raises risk, more female partners lowers it.
2 citations,
August 2020 in “Journal of The American Academy of Dermatology” High incidence of hair loss found in COVID-19 patients, but no severity correlation established.
1 citations,
March 2022 in “Irish Journal of Medical Science” Men with androgenetic alopecia and hypertension may experience more severe COVID-19.
119 citations,
May 2020 in “Journal of The American Academy of Dermatology” Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.
6 citations,
December 2020 in “Dermatological reviews” COVID-19 may worsen with androgens; anti-androgen drugs could help.
27 citations,
November 2020 in “International Journal of Dermatology” COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.
